Major Creative Shake-Ups Hit Paramount Horror Slate as David Bruckner Takes Over Smile 3 and Ben Wheatley Boards Molepeople
Major creative shifts are reshaping the horror slate at Paramount Pictures, reflecting a broader industry trend of high-profile shuffling among genre directors, writers, and high-stakes cinematic universes. According to recent industry reports, filmmaker David Bruckner has officially signed on to direct Smile 3, taking the reins of the wildly successful psychological horror franchise from Parker Finn. Finn, the visionary creator behind the original breakout hits, is transitioning to a producer role alongside Temple Hill, while concurrently tackling Paramount’s upcoming remake of Possession, slated for release on June 11, 2027.
Concurrently, the studio’s subterranean creature feature Molepeople—a joint venture between Paramount Primal and Blumhouse’s Atomic Monster—has experienced its own significant crew turnover. Director Rob Savage has departed the project, making way for filmmaker Ben Wheatley to step into the director’s chair. This dual-front creative transition underscores the immense pressures and fast-moving pipelines governing major studio horror franchises in an increasingly competitive theatrical marketplace.
The Evolution of the Smile Franchise and Bruckner’s Ascension
The Smile franchise has proven to be a financial and cultural powerhouse for Paramount Pictures. The original 2022 film, written and directed by Finn on a modest budget, became a global phenomenon, grossing over $217 million worldwide and redefining modern cinematic dread through its haunting, contagion-based grinning entity. Its 2024 sequel expanded the mythology into the pop music stratosphere, cementing the property as a reliable tentpole for the studio.
With Finn occupied by his reimagining of Andrzej Żuławski’s 1981 cult classic Possession, Paramount needed a proven genre architect to steer the third installment. Enter David Bruckner, whose resume establishes him as one of contemporary horror’s most reliable and visually sophisticated directors. Bruckner’s career trajectory includes acclaimed indie breakout features such as The Ritual (2017) and The Night House (2020), as well as high-profile studio work like the 2022 Hellraiser reboot for Hulu.
To pen the script for Smile 3, Bruckner will be working from a concept supplied by Finn, with a screenplay crafted by Nick Antosca. Antosca brings substantial prestige and dark-genre pedigree to the production, having previously written Antlers (2021), created the critically acclaimed television anthology Channel Zero, and developed the upcoming Cape Fear miniseries. While plot details for Smile 3 remain tightly under wraps, the combination of Bruckner’s atmospheric direction and Antosca’s psychological acuity signals a potentially darker, more cerebral expansion of the Smile universe.
In addition to Smile 3, Bruckner’s development slate remains remarkably robust. The filmmaker is currently attached to several high-profile literary and cinematic adaptations, including a remake of The Blob for Warner Bros., Universal’s The Caretaker, and A24’s Mice. This heavy workload highlights the high demand for directors capable of handling intellectual property with both commercial viability and distinct artistic vision.
Behind the Scenes of Molepeople: Savage and Stanfield Depart
While Smile 3 undergoes a smooth transition of power, Paramount Primal and Blumhouse’s Atomic Monster project Molepeople has faced a more turbulent pre-production phase. Rob Savage, who initially gained widespread recognition for his pioneering screenlife horror film Host (2020) and subsequent projects like Other Mommy, has parted ways with the film due to creative differences or scheduling realignments.
The departures do not stop in the director’s chair. Originally announced star LaKeith Stanfield—an Academy Award nominee known for his versatility in projects ranging from Judas and the Black Messiah to Sorry to Bother You—has also exited the film. Despite these major losses, the production has moved rapidly to secure replacement talent, tapping British filmmaker Ben Wheatley to helm the picture.
Molepeople is centered on a high-concept, claustrophobic premise: a man embarks on a harrowing and nightmarish descent into the forgotten, abandoned tunnels beneath New York City, where he discovers a dark, twisted society lurking under the streets. The screenplay was authored by Nathan Elston, who previously collaborated with Savage on Other Mommy. With Wheatley now directing, the film is actively maintaining its aggressive production timeline, targeting an August 27, 2027 theatrical release date.
Ben Wheatley’s Versatile Genre Background
Ben Wheatley’s appointment to Molepeople introduces a distinct directorial voice known for blending gritty realism, pitch-black humor, and surrealist terror. Wheatley first broke onto the international scene with his unsettling, micro-budget British crime-horror hybrid Kill List (2011), a film praised for its jarring shift from social realism to occult nightmare. He followed this with a string of idiosyncratic, critically lauded genre experiments, including A Field in England (2013) and In the Earth (2021).
Over the past several years, Wheatley has successfully transitioned into large-scale commercial filmmaking without abandoning his penchant for genre grit. His studio credits include steering the massive blockbuster Meg 2: The Trench (2023) and directing Bob Odenkirk in the action thriller Normal. Wheatley’s ability to navigate expansive studio budgets while maintaining atmospheric tension makes him a strategic choice to manage the subterranean terrors and complex creature-feature mechanics required by Molepeople.
Strategic Implications for Paramount’s Horror Strategy
The simultaneous shake-ups on Smile 3 and Molepeople illustrate the high-stakes environment of studio horror development in the mid-2020s. Horror has consistently outperformed almost every other genre at the box office relative to production costs, making intellectual property management a top priority for major studios like Paramount.
By pairing established horror franchises with seasoned auteurs—such as handing Smile 3 to Bruckner and Molepeople to Wheatley—Paramount is attempting to mitigate the fatigue that often plagues long-running cinematic series. Furthermore, the studio’s reliance on established creators from the independent and mid-tier horror spaces (such as Finn, Bruckner, Savage, and Wheatley) demonstrates a calculated industry shift toward filmmakers who understand modern audience anxieties and genre subversion.
As Smile 3 moves through its writing phase under Antosca and Bruckner, and as Wheatley steps in to re-anchor Molepeople for its late-summer 2027 release window, industry analysts will be watching closely. These leadership transitions, while disruptive in the short term, are designed to protect the long-term viability of Paramount’s horror pipeline, ensuring that both established universes and fresh concepts meet the elevated expectations of contemporary genre audiences.
